PD-L1-negative non-small cell lung cancer harbouring a rare BRAF mutation with successful treatment of first-line pembrolizumab plus chemotherapy: A case report and review the literature

Do, KH; Nguyen, TV; Bich, PNT; Nguyen, GH; Nguyen, CV

Do, KH (通讯作者)，Natl Canc Hosp Vietnam, Hosp K, Dept Med Oncol 1, 30 Cau Buou S, Hanoi, Vietnam.

RESPIROLOGY CASE REPORTS, 2023; 11 (6):

Abstract

BRAF mutations are uncommon in non-small cell lung cancer (NSCLC), accounting for less than 5% of all NSCLC cases. The utilization of targeted therapi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索